Treating EGFR Exon 20 Insertion+ mNSCLC: Equipping Oncology Nurses to Optimize Care

Download All
Deepen your understanding of treating EGFR exon 20 insertion–positive metastatic NSCLC with this comprehensive nursing program featuring an on-demand webcast and downloadable slidesets from a live symposium, along with a Clinical Resource PDF to help you talk with your patients about adverse events with agents targeting EGFR exon 20 insertion mutations.

Downloadable Summary Resource

Download this reference guide for key points on patient counseling, monitoring, and managing toxicities associated with approved therapies targeting EGFR exon 20 insertions in patients with NSCLC.

Released: April 28, 2022
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Takeda Pharmaceuticals U.S.A., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings